Sale is live|00:00:00
Avantel LtdQ1 FY22

Avantel Ltd

Q1 FY22 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • Avantel expects a sales/revenue growth of approximately 25% this year and around 20% the following year.
  • Profitability is anticipated to increase by 15-20%.
  • The company plans to expand its product spectrum in defence electronics including satellite communication.
  • Large orders include a railway order expected to be executed 50% in the current year and 50% in the next.
  • Pending order book stands at around ₹240 crores with additional expected orders of ₹60-70 crores this year.
  • Avantel aims to leverage opportunities in small satellites, expecting demand for thousands of such satellites annually and sees good growth potential.
  • The medical devices segment (Imeds) is projected to contribute to revenue in the medium term, with a team expected to be fully operational by October-November.
  • Supply chain challenges remain a risk factor but are actively managed.

Margin guidance

Category 3
  • The company expects a tentative 25% increase in sales (top line) and around 20% increase in profitability (bottom line).
  • A profitability increase of 15 to 20% is also considered very likely.
  • Expansion is planned in the Defence Electronics space with customized, innovative solutions and broadening the product spectrum.
  • Growth is driven by new orders, including a significant Indian Railways order and anticipated orders from both defence and medical electronics sectors.
  • The medical subsidiary, Imeds, is gearing up with a complete team by August and market launch expected around October-November, focusing on affordable healthcare products.
  • Supply chain challenges exist but are being managed through design changes and proactive procurement.
  • Listed plans include NSE listing in 2024, linked with equity and net worth milestones, to enhance liquidity and shareholder value.
  • Overall, the outlook is optimistic, with strong emphasis on R&D, order pipeline, and market diversification.

Sign up free to read the full earnings analysis

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Avantel Ltd and 1,400+ other companies.

Fundraise plans

  • The transcript does not mention any current or planned fundraising through debt or equity.
  • There is no indication of any immediate plans for raising funds via loans or share issuance.
  • The company is focusing on increasing net worth organically, aiming for over 75 crores to meet NSE listing eligibility by 2024.
  • No strategic investments or tie-ups involving equity infusion from companies like L&T or Tata Bell are on the cards currently.
  • The management emphasizes growth through internal accruals, increasing sales and profitability rather than external fundraising.

Order book

Yes
  • As of the meeting dated 30-05-2022, the pending order book is around ₹240 crores.
  • This includes ₹126 crores worth of Railway orders, with 50% to be executed in the current financial year and 50% in the next.
  • Expected execution for the current year is ₹130-140 crores.
  • An additional ₹60-70 crores worth of orders are anticipated during this financial year.
  • By the end of the current year, the total orders in hand for the next year are expected to be ₹160-170 crores.
  • Earlier, pending orders by July were roughly around ₹315 crores, but current figures are updated to ₹240 crores.
  • Large orders like the Railway 6300 locomotive project and Defence-related contracts contribute significantly to the order book.

Capex plans

Yes
  • The company is investing approximately 25 crores mostly towards small satellites, radars, and related facilities.
  • Investment in the medical device segment (Imeds) is planned but will not be very significant compared to the satellite and radar facilities.
  • Infrastructure for medical electronics is already set up at AMTZ Vizag, a world-class MedTech zone, with more than 100 crores invested in test facilities.
  • The company is continuously working on design changes to counter supply chain disruptions, particularly for semiconductors and connectors.
  • There is a focus on strategic, project-wise tie-ups with major companies like Bharat Electronics and L&T, and future collaboration possibility with the Tata group.
  • No current long-term strategic investments from L&T or Tata Bell but supportive projects underway.
  • Plans are in place to expand product range in Defence Electronics, satellite communication, and medical devices in the coming years.

How does Avantel Ltd rank vs peers in Aerospace & Defense?

Pro feature
1Avantel Ltd
Rev 3Mar 3

See full Aerospace & Defense sector rankings

Unlock with Pro

Want more stocks like Avantel Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio